Olympus

Asset

Hydrogel-based formulation of mitomycin delivering localized chemotherapy

Stage: Approved
Modality: Small molecule
Target: DNA damage response; 1
Indication: 0
Trials: 1
Developer

Indications

1

Low-grade upper tract urothelial cancer
Approved, news.google.com, Oct 28, 2026

In the full profile

Targets and what it contains1
Owner and partners1
Evidence for its targets1

Every asset’s record: target, stage, trials and the evidence behind it.